CINECA IRIS Institutional Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishNumerous clinical trials demonstrated that the optimal log-term treatment of pelvic pain caused by endometriosis may involve the use of GnRH ana- logues (GnRH-a) to suppress ovarian estrogen production combined with add- back low doses of estrogen plus progestin or progestin only. Estrogen, as a solitary add back, is less effective and thus is not indicated. Tibolone can be used as add back therapy to prevent hypoestrogenic symptoms. Recently, the post-operative administration of GnRH-a and anastrozole have been suggested to increase the pain-free interval and decrease symptom recurrence rates in patients following surgery for severe endometriosis.
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
| Titolo: | Double-Drug Regimen Using GnRH Analogues | |
| Autori: | ||
| Data di pubblicazione: | 2006 | |
| Abstract: | Numerous clinical trials demonstrated that the optimal log-term treatment of pelvic pain caused by endometriosis may involve the use of GnRH ana- logues (GnRH-a) to suppress ovarian estrogen production combined with add- back low doses of estrogen plus progestin or progestin only. Estrogen, as a solitary add back, is less effective and thus is not indicated. Tibolone can be used as add back therapy to prevent hypoestrogenic symptoms. Recently, the post-operative administration of GnRH-a and anastrozole have been suggested to increase the pain-free interval and decrease symptom recurrence rates in patients following surgery for severe endometriosis. | |
| Handle: | http://hdl.handle.net/11567/393068 | |
| ISBN: | 9788875872397 | |
| Appare nelle tipologie: | 04.01 - Contributo in atti di convegno |
File in questo prodotto:
Copyright © 2021